Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia

Mina Noura, Takahiko Yasuda, Shinobu Tsuzuki, Hidemasa Matsuo, Hitoshi Kiyoi, Fumihiko Hayakawa

Blood (2023) 142 (Supplement 1): 1405.

https://doi.org/10.1182/blood-2023-173640

Published: 2023

Journal Articles

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Blood (2022) 140 (Supplement 1): 6690–6692.

https://doi.org/10.1182/blood-2022-157438

Published: 2022

Journal Articles

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Blood (2022) 139 (12): 1850–1862.

https://doi.org/10.1182/blood.2021011921

Published: 2022

Includes: Supplemental data

Journal Articles

Leukemic Cells Expressing ETV6-Frk Identified in a Refractory B-ALL Patient Are Sensitive to Dasatinib in Vitro

Azusa Mayumi, Hideki Yoshida, Kouhei Mitsuno, Nozomi Nishida, Shinya Osone, Takahiko Yasuda, Toshihiko Imamura

Blood (2021) 138 (Supplement 1): 4335.

https://doi.org/10.1182/blood-2021-149926

Published: 2021

Journal Articles

Staurosporine Induces Caspase-Dependent Proteolysis of MEF2D-Fusion Protein and Cell Death Selective to MEF2D-Fusion-Positive ALL Cells

Naoyuki Tange, MD, Fumihiko Hayakawa, MD, PhD, Takahiko Yasuda, MD, PhD, Hideyuki Yamamoto, MD, Daiki Hirano, MD, PhD, Shinobu Tsuzuki, MD,PhD, Hitoshi Kiyoi, MD PhD

Blood (2019) 134 (Supplement_1): 1349.

https://doi.org/10.1182/blood-2019-123602

Published: 2019

Journal Articles

ZNF384-Fusion Proteins Have High Affinity to EP300, Which Increases Their Transcriptional Activities

Hideyuki Yamamoto, MD, Fumihiko Hayakawa, MD, PhD, Takahiko Yasuda, MD, PhD, Yuka Minamikawa, Naoyuki Tange, MD, Daiki Hirano, MD, Yuki Kojima, MD, PhD, Takanobu Morishita, MD, PhD, Shinobu Tsuzuki, MD, PhD, Hiroyuki Mano, MD,PhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2018) 132 (Supplement 1): 1554.

https://doi.org/10.1182/blood-2018-99-114414

Published: 2018

Journal Articles

Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia

Takahiko Yasuda, MD, PhD, Dai Nishijima, PhD, Shinya Kojima, PhD, Masahito Kawazu, MD, PhD, Toshihide Ueno, PhD, Shinobu Tsuzuki, MD PhD, Hitoshi Kiyoi, MD PhD, Itaru Matsumura, MD, Yasushi Miyazaki, MD PhD, Keizo Horibe, MD PhD, Hiroyuki Mano, MD, PhD, Tomoki Naoe, MD PhD, Masashi Sanada, MD PhD, Fumihiko Hayakawa, MD, PhD

Blood (2018) 132 (Supplement 1): 2821.

https://doi.org/10.1182/blood-2018-99-115716

Published: 2018

Journal Articles

High Expression of MEF2D-Fusion Protein Is Caused By Escaping from the Suppression By miRNA and Leads to Suppress Transcriptional Activity of PAX5

Hirano Daiki, MD, Fumihiko Hayakawa, MD PhD, Takahiko Yasuda, MDPhD, Naoyuki Tange, MD, Hideyuki Yamamoto, MD, Yuki Kojima, MD PhD, Takanobu Morishita, MD PhD, Naoto Imoto, MD PhD, Shinobu Tsuzuki, MDPhD, Hiroyuki Mano, MDPhD, Tomoki Naoe, MD PhD, Hitoshi Kiyoi, MD PhD

Blood (2017) 130 (Supplement 1): 3977.

https://doi.org/10.1182/blood.V130.Suppl_1.3977.3977

Published: 2017

Journal Articles

PAX5-PML Induces Pro B Acute Lymphoblastic Leukemia in Mice

Naoto Imoto, MD, Shingo Kurahashi, MD PhD, Fumihiko Hayakawa, MD PhD, Takahiko Yasuda, MD PhD, Keiki Sugimoto, Yuki Kojima, MD, Takanobu Morishita, MD, Yuichiro Inagaki, MD, Shinobu Tsuzuki, MD PhD, Tomoki Naoe, MDPhD, Hitoshi Kiyoi, MD PhD

Blood (2014) 124 (21): 887.

https://doi.org/10.1182/blood.V124.21.887.887

Published: 2014

Journal Articles

Drug Development Targeting Microenvironment for Malignant Lymphoma

Keiki Sugimoto, Fumihiko Hayakawa, MD, PhD, Takahiko Yasuda, MD, Ph.D., Tomoki Naoe, MD, PhD

Blood (2012) 120 (21): 1661.

https://doi.org/10.1182/blood.V120.21.1661.1661

Published: 2012

Journal Articles

B Cell Receptor-ERK1/2 Signal Cancels PAX5-Dependent Repression of BLIMP1 Probably Through PAX5 Phosphorylation: A Mechanism of Antigen-Triggering Plasma Cell Differentiation

Takahiko Yasuda, MD, Fumihiko Hayakawa, MD, PhD, Shingo Kurahashi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 1109.

https://doi.org/10.1182/blood.V118.21.1109.1109

Published: 2011

Journal Articles

PAX5 Phosphorylation by MAP Kinase Signal Potentially Suppresses PAX5 Function and Might Be a Trigger of the Plasma Cell Differentiation

Takahiko Yasuda, MD, Fumihiko Hayakawa, MD, PhD, Shingo Kurahashi, MD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 3898.

https://doi.org/10.1182/blood.V116.21.3898.3898

Published: 2010

Journal Articles

Corticosteroid Therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogeneous Leukemia and Myelodysplastic Syndrome Overt Leukemia.

Nobuhiko Imahashi, MD, Aika Seto, MD, Keisuke Watanabe, MD, Mayumi Yanagisawa, MD, Satoshi Nishiwaki, MD, Makoto Shinba, MD, Takahiko Yasuda, MD, Koichi Miyamura, MD, PHD, Yoshihisa Kodera, MD, PHD

Blood (2007) 110 (11): 1660.

https://doi.org/10.1182/blood.V110.11.1660.1660

Published: 2007

NARROW

Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia

Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

Leukemic Cells Expressing ETV6-Frk Identified in a Refractory B-ALL Patient Are Sensitive to Dasatinib in Vitro

Staurosporine Induces Caspase-Dependent Proteolysis of MEF2D-Fusion Protein and Cell Death Selective to MEF2D-Fusion-Positive ALL Cells

ZNF384-Fusion Proteins Have High Affinity to EP300, Which Increases Their Transcriptional Activities

Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia

High Expression of MEF2D-Fusion Protein Is Caused By Escaping from the Suppression By miRNA and Leads to Suppress Transcriptional Activity of PAX5

PAX5-PML Induces Pro B Acute Lymphoblastic Leukemia in Mice

Drug Development Targeting Microenvironment for Malignant Lymphoma

B Cell Receptor-ERK1/2 Signal Cancels PAX5-Dependent Repression of BLIMP1 Probably Through PAX5 Phosphorylation: A Mechanism of Antigen-Triggering Plasma Cell Differentiation

PAX5 Phosphorylation by MAP Kinase Signal Potentially Suppresses PAX5 Function and Might Be a Trigger of the Plasma Cell Differentiation

Corticosteroid Therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogeneous Leukemia and Myelodysplastic Syndrome Overt Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only